Clinical Associate Professor of Pathology
Director of Hematopathology
Campus Address:
M5242 Med Sci I
1301 Catherine Street
Ann Arbor, Michigan 48109-0602
Phone: 734/936-1873
wgfinn@umich.edu
Annual Report | Biography | Clinical Interests | Research Interests | Selected Publications
Departmental Annual Report
Brief Biography
Dr. Finn received both his undergraduate degree and M.D. from the University of Michigan in 1985 and 1989, respectively. He completed residency training in Anatomic and Clinical Pathology at Northwestern University, and also received subspecialty training in Hematopathology at Northwestern. He remained at Northwestern as an Assistant Professor until January 1998, when he joined the Department of Pathology at the University of Michigan. From 1995-1998, Dr. Finn was the Director of the Thorson-Goodall Molecular Oncology Laboratory at Northwestern Memorial Hospital in Chicago. In March 2001, Dr. Finn was appointed Director of Hematopathology at the University of Michigan.
Dr. Finn is a diplomate of the American Board of Pathology in Anatomic and Clinical Pathology, and is also certified by the ABP in Hematologic Pathology. He is active in all aspects of diagnostic hematopathology. His research interests have focused mainly upon the biologic diversity of chronic lymphocytic leukemia and other chronic lymphoproliferative disorders.
Clinical Interests
Pathology, Hematopathology, Bone marrow diseases, blood
diseases, lymph
node diseases, leukemia, lymphoma, chronic lymphocytic leukemia, myelodysplasia,
and acute leukemia.
Research Interests
Chronic lymphocytic leukemia, lymphoma, immunophenotyping, and flow cytometry.
Selected Publications
Uherova P, Ross CW, Schnitzer B,
Singleton TP, Finn WG. The clinical significance of CD10 antigen expression
in diffuse large B-cell lymphoma. Am J Clin Pathol 2001, 115:582-588.
Finn WG, Singleton TP, Schnitzer B, Ross CW, Stoolman LM. Adhesion molecule
expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison
with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic
leukemia. Hum Pathol 2001, 32:66-73.
Goolsby CL, Kuchnio M, Finn WG, Peterson L. Expansions of clonal and oligoclonal
T cells in B-cell chronic lymphocytic leukemia are primarily restricted
to the CD3+ CD8+ T-cell population. Cytometry 2000, 42:188-195.
Yang B, Tubbs RR, Finn W, Carlson A, Pettay J, Hsi ED. Clinicopathologic
reassessment of primary cutaneous B-cell lymphoma with immunophenotypic
and molecular genetic characterization. Am J Surg Pathol 2000, 24:694-702.
Finn WG, Kroft SH. New classifications for non-Hodgkin's lymphoma. Cancer
Treat Res 1999, 99:1-26.